Ratings
0
Nobody has rated this yet. Be the first!
Works
12
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer.
Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus
Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers
A rareRETgene exon 8 mutation is found in two Greek kindreds with familial medullary thyroid carcinoma: implications for screening
Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients
Triple-Negative Breast Cancer Risk Genes Identified by Multigene Hereditary Cancer Panel Testing
A Paternally Inherited BRCA1 Mutation Associated with an Unusual Aggressive Clinical Phenotype
Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?
BRCA1 and BRCA2 genes mutation analysis in patients with a family history of breast and ovarian cancer
